探索PPARγ复发性膀癌突变体中激活过程的分子途径
Vinícius M de Oliveira1, Caique C Malospirito1, Fernando B da Silva2
1Brazilian Biosciences National Laboratory, National Center for Research in Energy and Materials, LNBio/CNPEM, Campinas, SP, Brazil.
The Journal of chemical physics
|October 23, 2024
概括
氧酶增殖器激活受体马 (PPARγ) 的特定突变增强了它的活性,促进了膀癌. I290M突变稳定了活性受体状态,提供了一个潜在的治疗点.
科学领域:
- 分子生物学分子生物学
- 生物物理学的生物物理.
- 计算化学是一种计算化学.
背景情况:
- 过氧体增殖器激活受体马 (PPARγ) 对于葡萄糖恒温和脂肪生成至关重要.
- 它在癌症,特别是膀癌中的作用受到争论,一些证据表明它与瘤发生有关.
- PPARγ中的特定功能增益突变 (M280I,I290M,T475M) 与膀癌和受体激活有关,但其分子机制尚不清楚.
研究的目的:
- 为了研究过氧体增殖器激活受体马 (PPARγ) 在非活性和活性状态之间的构造动态.
- 检查膀癌相关突变 (M280I,I290M,T475M) 对PPARγ活性和稳定性的影响.
- 阐明这些突变导致PPARγ激活的分子通路.
主要方法:
- 采用基于双盆地结构的模型 (db-SBM) 进行分子动力学模拟.
- 分析了形状变化和静电相互作用.
- 通过生物物理分析验证的模拟结果.
主要成果:
- 突变I290M和T475M表现出增加的连接体独立转录活性.
- 与野生类型相比,I290M和T475M突变都提高了活跃PPARγ状态的稳定性.
- I290M突变促进了一条明显的过渡途径到活性状态,突出了K303和E488.8残留物.
- 生物物理测试证实,破坏K303-E488相互作用会取消在I290M突变体中观察到的热稳定.
结论:
- 该研究验证了模拟和化学信息学方法的结合,以了解分子激活机制.
- 确定了增强PPARγ活性的特定突变 (I290M,T475M),有助于膀癌.
- 确定了参与I290M介导激活的关键残留物 (K303,E488),这表明了治疗干预的潜在目标.
更多相关视频
相关概念视频
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K


